Catecholaminergic cell lines for the study of dopamine metabolism and neurotoxicity

Neuromethods

Volumn 56, Issue , 2011, Pages 383-402

  Segura Aguilar, Juan ^a  

^a UNIVERSITY OF CHILE   (Chile)

Author keywords

Aminochrome; Dopamine; MPTP (1 methyl 4 phenyl 1,2,3,6 tetrahydropyridine); Neuromelanin; Paraquat; Parkinson's disease; PC12; Rotenone; SH SY5Y

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 4 AMINOBUTYRIC ACID CARRIER; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADENOSINE TRIPHOSPHATE; ADENYLATE KINASE; AMINE OXIDASE (FLAVIN CONTAINING); DOPAMINE TRANSPORTER; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; MITOGEN ACTIVATED PROTEIN KINASE; NEUROMELANIN; OXIDOPAMINE; PARAQUAT; ROTENONE; TETRAZOLIUM; VESICULAR MONOAMINE TRANSPORTER 2;

ARTICLE; CATECHOLAMINE NERVE CELL; CELL DIFFERENTIATION; CELL GROWTH; CELL LINE; CULTURE MEDIUM; DEAMINATION; DOPAMINE METABOLISM; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME RELEASE; HUMAN; MITOCHONDRIAL MEMBRANE; NERVE DEGENERATION; NEUROTOXICITY; NONHUMAN; OXIDATION; PARKINSON DISEASE; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 79952605402     PISSN: 08932336     EISSN: 19406045     Source Type: Book Series    
DOI: 10.1007/978-1-61779-077-5_19     Document Type: Article

References (59)

1. Zecca L, Bellei C, Costi P, Albertini A, Monzani E, Casella L, Gallorini M et al (2008) New melanic pigments in the human brain that accumulate in aging and block environmental toxic metals. Proc Natl Acad Sci U S A 105:17567-17572
2. Zecca L, Fariello R, Riederer P, Sulzer D, Gatti A, Tampellini D (2002) The absolute concentration of nigral neuromelanin, assayed by a new sensitive method, increases throughout the life and is dramatically decreased in Parkinson's disease. FEBS Lett 510:216-220 (Pubitemid 34093828)
3. Segura-Aguilar J, Lind C (1989) On the mechanism of Mn3+ induced neurotoxicity of dopamine: Prevention of quinone derived oxygen toxicity by DT-diaphorase and superoxide dismutase. Chem Biol Interact 72:309-324 (Pubitemid 20011156)
4. Paris I, Dagnino-Subiabre A, Marcelain K, Bennett LB, Caviedes P, Caviedes R, Olea- Azar C, Segura-Aguilar J (2001) Copper neurotoxicity is dependent on dopamine-mediated copper uptake and one-electron reduction of aminochrome in a rat substantia nigra neuronal cell line. J Neurochem 77:519-529 (Pubitemid 32298746)
5. Paris I, Martinez-Alvarado P, Perez-Pastene C, Vieira MN, Olea-Azar C, Raisman-Vozari R, Cardenas S, Graumann R, Caviedes P, Segura-Aguilar J (2005) Monoamine transporter inhibitors and norepinephrine reduce dopamine-dependent iron toxicity in cells derived from the substantia nigra. J Neurochem 92:1021-1032 (Pubitemid 40344293)
6. Paris I, Perez-Pastene C, Couve E, Caviedes P, Ledoux S, Segura-Aguilar J (2009) Copper dopamine complex induces mitochondrial autophagy preceding caspase-independent apoptotic cell death. J Biol Chem 284:13306-13315
7. Segura-Aguilar J, Metodiewa D, Welch C (1998) Metabolic activation of dopamine o-quinones to o-semiquinones by NADPH cytochrome P450 reductase may play an important role in oxidative stress and apoptotic effects. Biochim Biophys Acta 1381:1-6 (Pubitemid 28248110)
8. Hastings TG (1995) Enzymatic oxidation of dopamine: The role of prostaglandin H synthase. J Neurochem 64:919-924
9. Segura-Aguilar J (1996) Peroxidase activity of liver microsomal vitamin D 25-hydroxylase and cytochrome P450 1A2 catalyzes 25-hydroxylation of vitamin D3 and oxidation of dopamine to aminochrome. Biochem Mol Med 58:122-129 (Pubitemid 26230536)
10. Galzigna L, De Iuliis A, Zanatta L (2000) Enzymatic dopamine peroxidation in substantia nigra of human brain. Clin Chim Acta 300:131-138 (Pubitemid 30665780)
11. Thompson CM, Capdevila JH, Strobel HW (2000) Recombinant cytochrome P450 2D18 metabolism of dopamine and arachidonic acid. J Pharmacol Exp Ther 294:1120-1130 (Pubitemid 30666868)
12. Terland O, Flatmark T, Tangeras A, Gronberg M (1997) Dopamine oxidation generates an oxidative stress mediated by dopamine semiquinone and unrelated to reactive oxygen species. J Mol Cell Cardiol 29:1731-1738 (Pubitemid 27270243)
13. Foppoli C, Coccia R, Cini C, Rosei MA (1997) Catecholamines oxidation by xanthine oxidase. Biochim Biophys Acta 1334:200-206 (Pubitemid 27117522)
14. Xu Y, Stokes AH, Freeman WM, Kumer SC, Vogt BA, Vrana KE (1997) Tyrosinase mRNA is expressed in human substantia nigra. Brain Res Mol Brain Res 45:159-162 (Pubitemid 27182239)
15. Paris I, Perez-Pastene C, Cardenas S, Iturriaga P, Muñoz P, Couve E et al (2010) Aminochrome induces disruption of actin, alpha-, and beta-tubulin cytoskeleton networks in substantia-nigra-derived cell line. Neurotox Res 18:82-92
16. Nirenberg M, Vaughan R, Uhl G, Kuhar M, Pickel V (1996) The dopamine transporter is localized to dendritic and axonal plasma membranes of nigrostriatal dopaminergic neurons. J Neurosci 16:436-447 (Pubitemid 26028804)
17. Augood SJ, Westmore K, McKenna PJ, Emson PC (1993) Co-expression of dopamine transporter mRNA and tyrosine hydroxylase mRNA in ventral mesencephalic neurones. Brain Res Mol Brain Res 20:328-334
18. Lorang D, Amara SG, Simerly RB (1994) Cell-type-specific expression of catecholamine transporters in the rat brain. J Neurosci 14:4903-4914 (Pubitemid 24237912)
19. Chen NH, Reith ME, Quick MW (2004) Synaptic uptake and beyond: The sodium- and chloridedependent neurotransmitter transporter family SLC6. Pflugers Arch 447:519-531 (Pubitemid 38241438)
20. Hitri A, Hurd YL, Wyatt RJ, Deutsch SI (1994) Molecular, functional and biochemical characteristics of the dopamine transporter: Regional differences and clinical relevance. Clin Neuropharmacol 17:1-22 (Pubitemid 24046702)
21. Zahniser NR, Sorkin A (2009) Trafficking of dopamine transporters in psychostimulant actions. Semin Cell Dev Biol 20:411-417
22. Melikian HE, Buckley KM (1999) Membrane trafficking regulates the activity of the human dopamine transporter. J Neurosci 19:7699-7710 (Pubitemid 30225770)
23. Sorkina T, Hoover BR, Zahniser NR, Sorkin A (2005) Constitutive and protein kinase C-induced internalization of the dopamine transporter is mediated by a clathrin-dependent mechanism. Traffic 6:157-170
24. Doolen S, Zahniser NR (2001) Protein tyrosine kinase inhibitors alter human dopamine transporter activity in Xenopus oocytes. J Pharmacol Exp Ther 296:931-938 (Pubitemid 32187367)
25. Moron JA, Zakharova I, Ferrer JV, Merrill GA, Hope B, Lafer EM et al (2003) Mitogenactivated protein kinase regulates dopamine transporter surface expression and dopamine transport capacity. J Neurosci 23:8480-8488 (Pubitemid 37158747)
26. Hoover BR, Everett CV, Sorkin A, Zahniser NR (2007) Rapid regulation of dopamine transporters by tyrosine kinases in rat neuronal preparations. J Neurochem 101:1258-1271 (Pubitemid 46718827)
27. Wersinger C, Sidhu A (2003) Attenuation of dopamine transporter activity by alpha-synuclein. Neurosci Lett 340:189-192 (Pubitemid 36369670)
28. Qian JJ, Cheng YB, Yang YP, Mao CJ, Qin ZH, Li K, Liu CF (2008) Differential effects of overexpression of wild-type and mutant human alpha-synuclein on MPP+-induced neurotoxicity in PC12 cells. Neurosci Lett 435:142-146
29. Fleckenstein AE, Metzger RR, Wilkins DG, Gibb JW, Hanson GR (1997) Rapid and reversible effects of methamphetamine on dopamine transporters. J Pharmacol Exp Ther 282:834-838 (Pubitemid 27340185)
30. Sandoval V, Riddle EL, Ugarte YV, Hanson GR, Fleckenstein AE (2001) Methamphetamineinduced rapid and reversible changes in dopamine transporter function: An in vitro model. J Neurosci 21:1413-1419 (Pubitemid 32128787)
31. LittleM KY, ElmerM LW, Zhong H, Scheys JO, Zhang L (2002) Cocaine induction of dopamine transporter trafficking to the plasma membrane. Mol Pharmacol 61:436-445 (Pubitemid 34112819)
32. Sundström E, Goldstein M, Jonsson G (1986) Uptake inhibition protects nigro-striatal dopamine neurons from the neurotoxicity of 1-methyl-4-phenylpyridine (MPP+) in mice. Eur J Pharmacol 131:289-292 (Pubitemid 17202498)
33. Hirata Y, Suzuno H, Tsuruta T, Oh-hashi K, Kiuchi K (2008) The role of dopamine transporter in selective toxicity of manganese and rotenone. Toxicology 244:249-256
34. Weyler W, Hsu YP, Breakefield XO (1990) Biochemistry and genetics of monoamine oxidase. Pharmacol Ther 47:391-417 (Pubitemid 20309559)
35. Shih JC, Grimsby J, Chen K (1997) Molecular biology of monoamine oxidase A and B: Their role in the degradation of serotonin. In: Baumgarten HG, Gothert M (eds) Handbook of experimental pharmacology, vol 129, serotoninergic neurons and 5-HT receptors in the CNS. Springer, Berlin, pp 655-670
36. Strolin-Benedetti M, Dostert P, Tipton KF (1992) Developmental aspects of the monoamine- degrading enzyme monoamine oxidase. Dev Pharmacol Ther 18:191-200 (Pubitemid 23159034)
37. Greene LA, Tischler AS (1976) Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc Natl Acad Sci U S A 73:2424-2428
38. Greene LA, Tischler AS (1982) PC12 pheochromocytoma cells in neurobiological research. Adv Cellular Neurobiol 3:373-414
39. Hashimoto W, Kitayama S, Kumagai K, Morioka N, Morita K, Dohi T (2005) Transport of dopamine and levodopa and their interaction in COS-7 cells heterologously expressing monoamine neurotransmitter transporters and in monoaminergic cell lines PC12 and SK-NSH. Life Sci 76:1603-1612 (Pubitemid 40170467)
40. Jiang H, Jiang Q, Feng J (2004) Parkin increases dopamine uptake by enhancing the cell surface expression of dopamine transporter. J Biol Chem 279:54380-54386 (Pubitemid 40053177)
41. Seitz G, Stegmann HB, Jäger HH, Schlude HM, Wolburg H, Roginsky VA et al (2000) Neuroblastoma cells expressing the noradrenaline transporter are destroyed more selectively by 6-fluorodopamine than by 6-hydroxydopamine. J Neurochem 75:511-520 (Pubitemid 30485432)
42. King SC, Tiller AA, Chang AS, Lam DM (1992) Differential regulation of the imipramine- sensitive serotonin transporter by cAMP in human JAr choriocarcinoma cells, rat PC12 pheochromocytoma cells, and C33- 14-B1 transgenic mouse fibroblast cells. Biochem Biophys Res Commun 183:487-491
43. Paris I, Lozano J, Cardenas S, Perez-Pastene C, Saud K, Fuentes P et al (2008) The catecholaminergic RCSN-3 cell line: A model to study dopamine metabolism. Neurotox Res 13:221-230
44. Bayer M, Kuçi Z, Schömig E, Gruündemann D, Dittmann H, Handgretinger R et al (2009) Uptake of mIBG and catecholamines in noradrenaline- and organic cation transporterexpressing cells: Potential use of corticosterone for a preferred uptake in neuroblastoma- and pheochromocytoma cells. Nucl Med Biol 36:287-294
45. Riherd DN, Galindo DG, Krause LR, Mayfield RD (2008) Ethanol potentiates dopamine uptake and increases cell surface distribution of dopamine transporters expressed in SK-N-SH and HEK-293 cells. Alcohol 42:499-508
46. Toyohira Y, Ueno S, Tsutsui M, Itoh H, Sakai N, Saito N, Takahashi K, Yanagihara N (2010) Stimulatory effects of the soy phytoestrogen genistein on noradrenaline transporter and serotonin transporter activity. Mol Nutr Food Res 54:516-524
47. Bryan-Lluka LJ, Bönisch H (1997) Lanthanides inhibit the human noradrenaline, 5-hydroxytryptamine and dopamine transporters. Naunyn Schmiedebergs Arch Pharmacol 355:699-706 (Pubitemid 27395695)
48. Suri C, Fung BP, Tischler AS, Chikaraishi DM (1993) Catecholaminergic cell-lines from the brain and adrenal-glands of tyrosine hydroxylase- SV40 T-antigen transgenic mice. J Neurosci 13:1280-1291 (Pubitemid 23067610)
49. Bundey RA, Kendall DA (1998) Inhibition of receptor-mediated calcium responses by corticotrophin- releasing hormone in the CATH.a cell line. Neuropharmacology 38:39-47 (Pubitemid 29073525)
50. Bouvier C, Avram D, Peterson VJ, Hettinger B, Soderstrom K, Murray TF, Leid M (1998) Catecholaminergic CATH.a cells express predominantly delta-opioid receptors. Eur J Pharmacol 348:85-93 (Pubitemid 28266757)
51. Qi Y, Wang JK, McMillian M, Chikaraishi DM (1997) Characterization of a CNS cell line, CAD, in which morphological differentiation is initiated by serum deprivation. J Neurosci 17:1217-1225 (Pubitemid 27073725)
52. Paris I, Martinez-Alvarado P, Cardenas S, Perez-Pastene C, Graumann R, Fuentes P, Olea-Azar C, Caviedes P, Segura-Aguilar J (2005) Dopamine-dependent iron toxicity in cells derived from rat hypothalamus. Chem Res Toxicol 18:415-419 (Pubitemid 40393163)
53. Adams FS, La Rosa FG, Kumar S, Edwards- Prasad J, Kentroti S, Vernadakis A et al (1996) Characterization and transplantation of two neuronal cell lines with dopaminergic properties. Neurochem Res 21:619-627 (Pubitemid 26151008)
54. Kaul S, Kanthasamy A, Kitazawa M, Anantharam V, Kanthasamy AG (2003) Caspase-3 dependent proteolytic activation of protein kinase C{Delta} mediates and regulates 1-methyl-4- phenylpyridinium (MPP+)-induced apoptotic cell death in dopaminergic cells: Relevance to oxidative stress in dopaminergic degeneration. Eur J Neurosci 18:1387-1401 (Pubitemid 37215094)
55. Kaul S, Anantharam V, Yang Y, Choi CJ, Kanthasamy A, Kanthasamy AG (2005) Tyrosine phosphorylation regulates the proteolytic activation of protein kinase C{Delta} in dopaminergic neuronal cells. J Biol Chem 280:28721-28730 (Pubitemid 41105773)
56. Sun F, Anantharam V, Zhang D, Latchoumycandane C, Kanthasamy A et al (2006) Proteasome inhibitor MG-132 induces dopaminergic degeneration in cell culture and animal models. Neurotoxicology 27:807-815 (Pubitemid 44232996)
57. Cunningham RL, Giuffrida A, Roberts JL (2009) Androgens induce dopaminergic neurotoxicity via caspase-3-dependent activation of protein kinase Cdelta. Endocrinology 150:5539-5548
58. Manakova S, Puttonen KA, Raasmaja A, Männistö PT (2004) The roles of dopamine transporter and Bcl-2 protein in the protection of CV1-P cells from 6-OHDA-induced toxicity. Toxicol Lett 154:117-123 (Pubitemid 39314595)
59. Rodríguez-Martín E, Casarejos MJ, Bazán E, Canals S, Herranz AS, Mena MA (2000) Nitric oxide induces differentiation in the NB69 human catecholamine-rich cell line. Neuropharmacology 39:2090-2100 (Pubitemid 30645632)